Zusammenfassung
Hintergrund
In den letzten 20 Jahren haben sich zahlreiche transurethrale endoskopische Enukleationstechniken als Konkurrenz zur offenen Adenomenukleation (offene Prostataenukleation, OP) und transurethralen Resektion der Prostata (TURP) etabliert. Seit der diesjährigen Novelle der „EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS) inclusive benign prostatic obstruction (BPO)“ werden Holmium-Laserenukleation (HoLEP) und bipolare Enukleation als anatomische endoskopische Enukleationstechniken (EEP) subsummiert und als Verfahren der ersten Wahl zur Behandlung der BPO bezeichnet.
Fragestellung
Die verfügbare Datenlage zu Langzeitergebnissen aller EEP wird dargestellt.
Material und Methode
Pubmed/Medline- und Scopus-Suche mit folgendem Suchalgorythmus: long term, HoLEP, ThuLEP, vapoenucleation, TmLEP, ThuVARP, vaporesection, ThuVEP, DiLEP, ELEP, GreenlEP, Greenlight enucleation, bipolar enucleation, plasmakinetic enucleation, monopolar enucleatino und transurethral enucleation. Selektion von Studien mit einem Nachbeobachtungszeitraum ≥48 Monate.
Ergebnisse
Es wurden 5 randomisiert kontrollierte Studien (2 HoLEP, 2 biplare Enukleation, 1 Thulium-Laserresektion der Prostata in Tangerine-Technik [TmLR-TT]), 3 prospektive Kohortenstudien: 2 Thulium-Vapoenukleation [ThuVEP], 1 TmLRP-TT) sowie 2 retrospektive Studien mit hoher Patientenzahl ausgewählt. Alle EEP erwiesen sich bezüglich der Effektivität und Nachhaltigkeit gleichwertig der Operation. Die Adenomrezidivoperationsrate von HoLEP, ThuVEP, bipolarer Enukleation und Tangerine-Technik (TmLRP-TT) liegt bei 0–1,2 %, die Urethrotomierate bei 1,9–3,75 %, die Blasenhalsresektionsrate bei 0,9–4 %. Es ergab sich für die Einzelstudien kein signifikanter Unterschied zur Operation. Im Vergleich bipolare Enukleation vs. TURP waren nach 60 Monaten die Parameter maximaler Harnfluss, Restharn und IPSS signifikant besser für bipolare Enukleation. Beim Vergleich TmLRP-TT und TURP nach 48 Monaten fand sich kein signifikanter Unterschied.
Schlussfolgerung
Verschiedene transurethrale endoskopische Enukleationen (EEP) der Prostata können vor dem Hintergrund der transurethralen anatomischen Enukleation der Prostata als gleichermaßen sicher und effektiv für die Behandlung der BPO betrachtet werden. Alle EEP erreichen die Nachhaltigkeit der offenen Operation. Die Wahl der Energiequelle für die EEP erscheint vor diesem Hintergrund sekundär und eher bedingt durch die Verfügbarkeit von Ressourcen oder persönliche Präferenz des erfahrenen Operateurs bedingt.
Abstract
Background
In the last 20 years various transurethral endoscopic enucleation techniques (EEP) have been established as a substitute for open prostatectomy (OP) and TURP. Since the 2016 update of the “EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), including Benign Prostatic Obstruction (BPO)”, Holmium laser enucleation of the prostate (HoLEP) and bipolar enucleation being summarized as anatomical enucleating techniques are proposed as first choice for the surgical management of BPO of large volume prostates.
Objectives
The purpose of this review is to demonstrate the available data on long-term outcomes of current EEP techniques.
Materials and methods
PubMed/Medline and Scopus were searched using the terms: long term, HoLEP, ThuLEP, ThuVEP, DiLEP, ELEP, GreenlEP, Greenlight enucleation, bipolar enucleation, plasmakinetic enucleation, monopolar enucleation, and transurethral enucleation. Studies with a follow-up ≥48 months were selected.
Results
In all, 5 randomized controlled trials (2 HoLEP, 2 bipolar enucleation, 1 Thulium laser resection of the prostate in tangerine technique [TmLR-TT]), 3 prospective cohort studies (2 thulium vapoenucleation [ThuVEP], 1 TmLRP-TT), and 2 retrospective studies with large patient cohorts were selected. All EEP were equivalent to OP with regard to effectivity and durability of results. The rate of secondary surgical procedures in HolEP, ThuVEP, bipolar enucleation and tangerine technique (TmLRP-TT) was 0–1.2 % for reTURP, 1.9–3.75 % for urethrotomy, and 0.9–4 % for bladder neck resection. No significant difference in the individual studies was found when compared to OP. For bipolar enucleation vs. TURP long-term results for uroflow, residual urine, and IPSS were significantly better at 60 months for bipolar enucleation. One RCT TmLRP-TT vs. TURP at the 48-month follow-up found no significant difference.
Conclusion
Various transurethral EEP can be considered as equally safe and effective anatomical enucleation techniques. All displayed EEPs match the durability of OP. The choice of energy source for EEP seems to be secondary and a function of resources and personal preference of the skilled surgeon.
Literatur
Fraundorfer MR, Gilling PJ (1998) Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 33(1):69–72
Hiraoka Y (1983) A new method of prostatectomy, transurethral detachment and resection of benign prostatic hyperplasia. Nippon Ika Daigaku Zasshi 50(6):896–898
Gilling PJ (2013) Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases – a. Medium-term Prospect Randomized Comp BJU Int 111(5):694–695. doi:10.1111/j.1464-410X.2012.11752.x
Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51. doi:10.1007/s00345-009-0503-0
Elkoushy MA, Elhilali MM (2016) Management of Benign Prostatic Hyperplasia Larger than 100 ml: Simple Open Enucleation Versus Transurethral Laser Prostatectomy. Curr Urol Rep 17(6):44. doi:10.1007/s11934-016-0601-7
El-Hakim A, Elhilali MM (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90(9):863–869 (Dec)
Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27(4):541–545. doi:10.1007/s00345-008-0370-0
El-Hakim A, Elhilali MM (2002) Holmium laser enucleation of the prostate can be taught: the first learning experience. BJU Int 90(9):863–869 (Dec)
Hochreiter WW, Thalmann GN, Burkhard FC, Studer UE (2002) Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol 168(4 Pt 1):1470–1474 (Oct)
Rassweiler J, Roder M, Schulze M, Muschter R (2008) Transurethrale Laserenukleation der Prostata mit dem Holmiumlaser. Urologe A 47(4):441–448. doi:10.1007/s00120-008-1684-7
Xia SJ, Two-micron (2009) (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian J Androl 11(3):277–281. doi:10.1038/aja.2009.17
Cui D, Sun F, Zhuo J, Sun X, Han B, Zhao F, Jing Y, Lu J, Xia S (2014) A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol 32(3):683–689. doi:10.1007/s00345-013-1103-6
Bach T, Huck N, Wezel F, Häcker A, Gross AJ, Michel MS (2010) 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. BJU Int 106(3):368–372 (Aug)
Herrmann TR (2016). ThuLEP in Oyster-technique. In: 5th Meeting of the EAU Section of Uro-Technology, Athen, 2016
Bach T, Xia SJ, Yang Y, Mattioli S, Watson GM, Gross AJ, Herrmann TR. Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol. 2010 Apr;28(2):163–8. doi: 10.1007/s00345-010-0522-x. Epub 2010 Mar 5
Gomez Sancha F, Rivera VC, Georgiev G, Botsevski A, Kotsev J, Herrmann T. Common trend: move to enucleation – Is there a case for GreenLight enucleation? Development and description of the technique. World J Urol. 2015 Apr;33(4):539–47. doi: 10.1007/s00345-014-1339-9. Ep ub 2014 Jun 15
Lusuardi L, Hruby S, Janetschek G, Mitterberger M, Sieberer M, Colleselli D, Kunit T, Hitzl W, Kloss B.Laparoscopic adenomectomy versus Eraser laser enucleation of the prostate. World J Urol. 2015 May;33(5):691–6. doi: 10.1007/s00345-014-1476-1. Epub 2015 Jan 3
Xu A, Zou Y, Li B, Liu C, Zheng S, Li H, Xu Y, Chen B, Xu K, Shen H (2013) A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia. J Endourol 27(10):1254–1260 (Oct)
Lin Y, Wu X, Xu A, Ren R, Zhou X, Wen Y, Zou Y, Gong M, Liu C, Su Z, Herrmann TR (2015) Transurethral enucleation of the prostate versus transvesical open prostatectomy for large benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. World J Urol. doi:10.1007/s00345-015-1735-9
Li M, Qiu J, Hou Q, Wang D, Huang W, Hu C, Li K, Gao X. Endoscopic enucleation versus open prostatectomy for treating large benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. PLoS One. 2015 Mar 31;10(3):e0121265. doi: 10.1371/journal.pone.0121265. eCollection 2015
Neill MG, Gilling PJ, Kennett KM, Frampton CM, Westenberg AM, Fraundorfer MR, Wilson LC (2006) Randomized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology 68(5):1020–1024 (Nov)
Zhu L, Chen S, Yang S, Wu M, Ge R, Wu W, Liao L, Tan J. Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5‑year followup. J Urol. 2013 Apr;189(4):1427–31. doi: 10.1016/j.juro.2012.10.117. Epub 2012 Oct 31
Wolters M, Huusmann S, Oelke M, Kuczyk MA, Herrmann TRW. Anatomical Enucleation of the Prostate with the Novel Combined Mechanical and Bipolar Vaporization Probe in Ejaculation Sparing and Two-Lobe Manner. Videourology. First published January 2016. doi: 10.1089/vid.2016.0028
Zhang K, Sun D, Zhang H, Cao Q, Fu Q (2015) Plasmakinetic Vapor Enucleation of the Prostate with Button Electrode versus Plasmakinetic Resection of the Prostate for Benign Prostatic Enlargement >90 ml: Perioperative and 3‑Month Follow-Up Results of a Prospective, Randomized Clinical Trial. Urol Int 95(3):260–264. doi:10.1159/000381753
Zhu Y, Zhuo J, Xu D, Xia S, Herrmann TR. Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis. World J Urol. 2015 Apr;33(4):509–15. doi: 10.1007/s00345-014-1410-6. Epub 2014 Oct 9
Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR, Bayer T, Knoll T, Abbou CC, Janetschek G, Bachmann A, Rassweiler JJ (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61(2):317–325. doi:10.1016/j.eururo.2011.10.009
Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N’dow J, Nordling J, de la Rosette JJ (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. European Association of Urology. Eur Urol 64(1):118–140 (Jul)
Herrmann TR, Liatsikos EN, Nagele U, Traxer O, Merseburger AS; EAU Guidelines Panel on Lasers, Technologies. EAU guidelines on laser technologies. Eur Urol. 2012 Apr;61(4):783–95.E
Gravas S, Bach T, Bachmann A, Drake M, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C (2016) K.A.O. Tikkinen Guidelines Associates: M. Karavitakis, S. Malde, V. Sakkalis, R. Umbach. EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urology 2016, S 1–62
Wissenschaftliches Institut der AOK (WIdO) (2014) Entwicklung des Leistungsbereichs Prostataoperation bei Benigner Prostataobstruktion Abschlussbericht. WIdO, Berlin
Tinmouth WW, Habib E, Kim SC, Kuo RL, Paterson RF, Terry CL, Elhilali M, Lingeman JE (2005) Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol 19(5):550–554 (Jun)
Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM (2009) Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy. Urology 74(5):1105–1110 (Nov)
Netsch C, Bach T, Herrmann TR, Gross AJ (2014) World J Urol. 2015 Apr. Update Curr Evid Tm:yag Vapoenucleation Prostate 33(4):517–524. doi:10.1007/s00345-014-1417-z
Kim YJ, Lee YH, Kwon JB, Cho SR, Kim JS. A novel one lobe technique of thulium laser enucleation of the prostate: ‘All-in-One’ technique. Korean J Urol. 2015 Nov;56(11):769–74. doi: 10.4111/kju.2015.56.11.769. Epub 2015 Nov 3
Kim JW, Kim YJ, Lee YH, Kwon JB, Cho SR, Kim JS. An Analytical Comparison of Short-term Effectiveness and Safety Between Thulium:YAG Laser Vaporesection of the Prostate and Bipolar Transurethral Resection of the Prostate in Patients With Benign Prostatic Hyperplasia. Korean J Urol. 2014 Jan;55(1):41–6. doi: 10.4111/kju.2014.55.1.41. Epub 2014 Jan 15
Misrai V, Kerever S, Phe V, Zorn KC, Peyronnet B, Rouprêt M. Direct Comparison of GreenLight Laser XPS Photoselective Prostate Vaporization and GreenLight Laser En Bloc Enucleation of the Prostate in Enlarged Glands Greater than 80 ml: a Study of 120 Patients. J Urol. 2016 Apr;195(4P1):1027–32. doi: 10.1016/j.juro.2015.10.080. Epub 2015 Oct 17
Liu C, Zheng S, Li H, Xu K (2010) Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasmakinetics. J Urol 184:2440–2445
Thomas JA, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyère F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitán C, Knispel H, Bachmann A. A Multicenter Randomized Noninferiority Trial Comparing GreenLight-XPS Laser Vaporization of the Prostate and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Obstruction: Two-yr Outcomes of the GOLIATH Study. Eur Urol. 2016 Jan;69(1):94–102. doi: 10.1016/j.eururo.2015.07.054. Epub 2015 Aug 15
Lebdai S, Delongchamps NB, Sapoval M, Robert G, Amouyal G, Thiounn N, Karsenty G, Ruffion A, de La Taille A (2016) Descazeaud A, Mathieu R. Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia. World J Urol 34(5):625–632. doi:10.1007/s00345-015-1665-6
Gilling PJ, Wilson LC, King CJ, Westenberg AM, Frampton CM, Fraundorfer MR. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012 Feb;109(3):408–11. doi: 10.1111/j.1464-410X.2011.10359.x
Sun F, Han B, Cui D, Zhao F, Sun X, Zhuo J, Jing Y, Liu H, Xia S, Yang Y, Luo G, Guo F (2015) Long-term results of thulium laser resection of the prostate: a prospective study at multiple centers. World J Urol 33(4):503–508. doi:10.1007/s00345-014-1456-5
Chen S, Zhu L, Cai J, Zheng Z, Ge R, Wu M, Deng Z, Zhou H, Yang S, Wu W, Liao L, Tan J. Plasmakinetic Enucleation of the Prostate Compared with Open Prostatectomy for Prostates Larger Than 100 Grams: A Randomized Noninferiority Controlled Trial with Long-term Results at 6 Years. Eur Urol. 2014 Jan 24. pii: S0302–2838(14)00022-0. doi: 10.1016/j.eururo.2014.01.010
Zhu L, Chen S, Yang S et al (2013) Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5‑year followup. J Urol 189:1427–1431
Netsch C, Engbert A, Bach T, Gross AJ (2014) Long-term outcome following Thulium VapoEnucleation of the prostate. World J Urol 32(6):1551–1558. doi:10.1007/s00345-014-1260-2
Netsch C, Jakobler D, Bach Thorsten, Gross AJ. Thulium VapoEnucleation of the prostate (ThuVEP): long-term results during 6‑year follow-up of 500 procedures Login to Access Video or Poster Abstract: MP13–10 J Urol Suppl 2015. Vol. 193, No. 4S, e140
Kuntz RM, Lehrich K, Ahyai SA (2008) Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5‑year follow-up results of a randomised clinical trial. Eur Urol 53(1):160–166 (Jan)
Elmansy HM, Kotb A, Elhilali MM (2011) Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup. J Urol 186(5):1972–1976. doi:10.1016/j.juro.2011.06.065
Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P (2011) Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 108(7):1132–1138. doi:10.1111/j.1464-410X.2010.09993.x
Chapple CR, Osman NI, Birder L, van Koeveringe GA, Oelke M, Nitti VW, Drake MJ, Yamaguchi OA (2015) P, Smith PP. The underactive bladder: a new clinical concept? Eur Urol 68(3):351–353. doi:10.1016/j.eururo.2015.02.030
Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol. 2008 Aug;54(2):419–26. doi: 10.1016/j.eururo.2008.02.017. Epub 2008 Feb 25
Oelke M, Adler E, Marschall-Kehrel D, Herrmann TR, Berges R, Nocturia (2014) state of the art and critical analysis of current assessment and treatment strategies. World J Urol 32(5):1109–1117. doi:10.1007/s00345-014-1396-0
Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CGM- (2010) analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384–397. doi:10.1016/j.eururo.2010.06.005
Shah HN, Mahajan AP, Hegde SS, Bansal MB. Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int. 2007 Jul;100(1):94–101
Seki N, Mochida O, Kinukawa N, Sagiyama K, Naito S (2003) Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol 170:1847–1850
Elzayat EA, Habib EI, Elhilali MM (2005) Holmium laser enucleation of the prostate: a size-independent new ‘gold standard‘. Urology 66((Suppl):108–113
Madersbacher S, Lackner J, Brössner C, Röhlich M, Stancik I, Willinger M, Schatzl G; Prostate Study Group of the Austrian Society of Urology. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol. 2005 Apr;47(4):499–504. Epub 2005 Jan 23
Netsch C, Bach T, Herrmann TR, Gross AJ (2014) World J Urol. 2015 Apr. Update Curr Evid Tm:yag Vapoenucleation Prostate 33(4):517–524. doi:10.1007/s00345-014-1417-z
Kyriazis I, Świniarski PP, Jutzi S, Wolters M, Netsch C, Burchardt M, Liatsikos E, Xia S, Bach T, Gross AJ, Herrmann TR (2015) Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement. World J Urol 33(4):525–530. doi:10.1007/s00345-015-1529-0
Zhu Y, Zhuo J, Xu D, Xia S, Herrmann TR (2015) Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis. World J Urol 33(4):509–515. doi:10.1007/s00345-014-1410-6
Feng L, Zhang D, Tian Y, Song J. Thulium Laser Enucleation Versus Plasmakinetic Enucleation of the Prostate: A Randomized Trial of a Single Center. J Endourol. 2016 Jun;30(6):665–70. doi: 10.1089/end.2015.0867
Herrmann TR. Enucleation is enucleation is enucleation is enucleation. World J Urol. 2016 Sep 1. [Epub ahead of print]. doi:10.1007/s00345-016-1922-3
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
T.R. Herrmann gibt Beratertätigkeit, Vortragshonorare Karl Storz GmbH. Beratertätigkeit, Vortragshonorare, Advisory Board Boston Scientific; Vortragshonorare LisaLaser oHG; Vortragshonorare Asclepion, Advisory Board, Beratertätigkeit; Vortragshonrare Ipsen Pharma AG, Kongressgebühren Janssen an. Der Autor gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Herrmann, T.R.W. Langzeitergebnisse nach endoskopischer Enukleation der Prostata. Urologe 55, 1446–1454 (2016). https://doi.org/10.1007/s00120-016-0245-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-016-0245-8